Nascent Biotech INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Nascent Biotech, a clinical-stage biopharmaceutical company, reported its full-year 2024 results, highlighting progress in its Pritumumab clinical trials and financial position.